California Lutheran University launching new MBA program
The California Lutheran University School of Management will launch a new MBA program tailored to experienced professionals this fall. The MBA for Experienced Professionals program is designed for people with at least five years of progressive managerial or professional experience. The 18-month program will be delivered in a hybrid format with seven courses offered online Read More →
Amgen to pay dividend of $1 per share
Thousand Oaks-based biotech giant Amgen announced it will pay a second quarter dividend of $1 per share. Amgen increased its first quarter dividend to $1 per share from 79 cents on Dec. 15, which Amgen paid to shareholders during each quarter last year. Amgen will pay the dividend on June 8 to shareholders who own Read More →
Baxalta laying off 100 employees in Thousand Oaks
Baxalta, a biotechnology company with 1,200 employees in Thousand Oaks, is laying off 100 workers at that office on May 1. Layoffs will affect 239 Baxalta employees across the state at offices in Thousand Oaks, Los Angeles and Van Nuys, according to notices filed March 2 with the state of California. At Baxalta’s office at Read More →
Future of privacy at stake in Apple v. FBI
A highly contentious legal battle is brewing between Apple and the FBI. The FBI has been trying to hack into the encrypted iPhone belonging to Syed Farook, one of the San Bernardino shooters in the Dec. 2 attack that killed 14 people. The Apple iPhone, which was actually issued by the county of San Bernardino, Read More →
Ceres fires KPMG over financial report
Ceres Inc. fired its accounting firm Feb. 23 during a disagreement over a “going concern” statement in Ceres’ 2015 annual report. Ceres, a Thousand Oaks-based ag-biotech company, made the announcement in a filing with the Securities and Exchange Commission. The filing says Ceres hired Los Angeles-based Marcum as its new independent accountant and dismissed its Read More →
Amgen selling $708 million in bonds to Swiss
Thousand Oaks-based biotech giant Amgen said Feb. 23 it will sell about $700 million in bonds on the Swiss market. Amgen said it would sell 700 million Swiss Francs worth of bonds. That equals about $708 million. Amgen submitted the bonds to the Swiss market for pricing Feb. 23 and said it expected to sell Read More →